Oakes Benjamin L. bought SCTX
July 23, 2026 · Form 4 insider transaction
Oakes Benjamin L. bought 429,599 shares of Scribe Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
429,599
Price
$0.00
Total value
N/A
InsiderOakes Benjamin L.
RoleOfficer, Director
SecurityPerformance-based Stock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJuly 23, 2026
Filing dateJuly 27, 2026
Shares owned after429,599
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The options are eligible to vest upon the achievement of certain market-based performance criteria during a performance period beginning on July 23, 2026 and ending on July 23, 2029, subject to the Reporting Person's provision of service to the Issuer on each vesting date.